A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.,Haematologica

当前位置： X-MOL 学术 › Haematologica › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Haematologica ( IF 8.2 ) Pub Date : 2024-12-01 , DOI: 10.3324/haematol.2023.284730
Hang Quach ₁ , Gurdeep Parmar ₂ , Enrique M Ocio ₃ , H Miles Prince ₄ , Albert Oriol ₅ , Helen Crowther ₆ , Nobuhiro Tsukada ₇ , Pierre Bories ₈ , Sumit Madan ₉ , Nitya Nathwani ₁₀ , Kazutaka Sunami ₁₁ , Dorothee Semiond ₁₂ , Disa Yu ₁₂ , Paul Cordero ₁₃ , Sandrine Macé ₁₄ , Florence Suzan ₁₄ , Philippe Moreau ₁₅

Affiliation

Dept. of Hematology, St Vincent's Hospital, University of Melbourne,.
Illawarra Cancer Care Centre, Wollongong, NSW, Australia.
Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.
Molecular Oncology and Cancer Immunology, Epworth Healthcare and University of Melbourne, Melbourne, Vic, Australia.
Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.
Department of Hematology, Blacktown and Mount Druitt Hospitals, Blacktown, NSW, Australia.
Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Early Phase Unit, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
MD Anderson Cancer Center, Gilbert, AZ.
Department of Hematology, City of Hope National Medical Center, Duarte, CA.
Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
Sanofi, Research and Development, Cambridge, MA.
Sanofi, Research and Development, Reading.
Sanofi, Research and Development, Vitry-sur-Seine.
Department of Hematology, University Hospital of Nantes, Nantes, France.